The company received USFDA approval for nonsteroidal anti-inflammatory drug, which will be produced at Ahmedabad facility.

The company said that the medicine is used to treat pain or inflammation caused by many conditions such as arthritis, ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Zydus Lifesciences gets USFDA nod for Celecoxib capsules. The approval includes various strengths of the drug. It will ...

Biocon and Zydus Lifesciences are in the spotlight with fresh regulatory approvals fueling bullish analyst sentiment and renewed retail interest. Biocon shares rose 2% on Wednesday after its ...

The Nasdaq Composite posted its latest record finish on Tuesday, supported by a jump in shares of heavyweight Nvidia, but the ...

Dubai: Share prices of Indian pharmaceutical companies – and especially those with high export volumes – are coming under investor spotlight after the latest tariff threat from US President Trump. Of ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg. Celecoxib is a nonsteroidal ...

Stocks including HDFC Life Insurance, ICICI Lombard GIC, Bajaj Finserv, HDB Financial, Ashok Leyland, Zydus Lifesciences, ...

The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organisation (CDSCO) ...

After identifying the top-100 large cap stocks, the stocks ranked 101st to 250th by market cap qualify as mid-cap stocks.

Aspire Impact, an ESG, sustainability, and impact ratings initiative, has launched a new sector-focused report titled ...